Novogene Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Ruiqiang Li
Chief executive officer
CN¥416.1k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.4yrs |
| CEO ownership | 53.0% |
| Management average tenure | no data |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
Novogene Co., Ltd.'s (SHSE:688315) Share Price Is Matching Sentiment Around Its Earnings
Feb 06
Should You Think About Buying Novogene Co., Ltd. (SHSE:688315) Now?
Jan 02Earnings Working Against Novogene Co., Ltd.'s (SHSE:688315) Share Price
Sep 27Some Confidence Is Lacking In Novogene Co., Ltd. (SHSE:688315) As Shares Slide 26%
Jun 07Time To Worry? Analysts Are Downgrading Their Novogene Co., Ltd. (SHSE:688315) Outlook
Apr 17Estimating The Fair Value Of Novogene Co., Ltd. (SHSE:688315)
Mar 25CEO
Ruiqiang Li (45 yo)
Dr. Li Ruiqiang is Founder of Novogene Co., Ltd. Dr. Ruiqiang serves as Chairman of the Board and Chief Executive Officer at Novogene Co., Ltd. and serves as its Director since June 15, 2019.Dr. Ruiqiang...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 6.4yrs | CN¥416.10k | 53.03% CN¥ 3.1b | |
| Deputy GM | 6.4yrs | CN¥1.21m | no data | |
| Independent Director | 3.4yrs | CN¥120.00k | no data | |
| Supervisor | 3.4yrs | no data | no data | |
| Supervisor | 3.4yrs | no data | no data | |
| Employee Representative Chairman of the Supervisory Board | 3.4yrs | no data | no data | |
| Independent Director | 2.2yrs | CN¥120.00k | no data | |
| Director | 3.4yrs | no data | no data |
Experienced Board: 688315's board of directors are considered experienced (3.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/07 09:03 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Novogene Co., Ltd. is covered by 10 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Shiyu Chen | China International Capital Corporation Limited |
| Yuan Gao | China International Capital Corporation Limited |